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Abstract: In this work, crystal structures of commercially available photochromic compounds, i.e.,
spiropyrans and spirooxazines, were investigated by single-crystal X-ray diffraction. A total of five
new structures were obtained via isothermal evaporation experiments under different conditions,
namely 1,3,3-Trimethylindolino-benzopyrylospiran (I), 1,3,3-Trimethylindolinonaphtospirooxaxine (II),
1-(2-Hydroxyethyl)-3,3-dimethylindolino-6′-nitrobenzopyrylospiran (III), and 1,3,3-Trimethylindolino-
8′-methoxybenzopyrylospiran (IVa and IVb). Since the basic structure of a spiropyran/-oxazine
does not present typical hydrogen bond accepting and donating groups, this study illustrates the
importance of additional functional groups connected to this kind of molecules to induce specific
intermolecular interactions. Our results show that possible hydrogen bonding interactions are rather
weak due to the high steric demand of these compounds. These results are supported by a search of
the Cambridge structural database focused on related structures.
Keywords: spiropyran; spirooxazine; crystal engineering; photochromic compounds; crystal
structure
1. Introduction
Spiropyran and spirooxazine are photochromically active compounds. Their photochromic
character stems from a ring-opening isomerization by breaking the Cspiro-O bond upon UV-light
absorption [1]. Spiropyrans are usually found non-photochemically active in solid state at ambient
conditions. The limited solid-state response of the compounds is expected to be due to the large
structural changes accompanying the ring opening mechanism. In principle, this issue can be
tackled using the so-called chemical modification method, in which the spiro compound is given
functional groups large enough to open up the crystal structure, allowing the compound to become
photochromically active at the solid state. This approach, however, turned out to be challenging [2].
Another approach consists in modifying the crystal structures by a crystal engineering approach. In
this approach, one does not chemically change the form of the original compound, but one targets
a modification of the crystal structure. Former investigations of related photo- and thermochromic
compounds (i.e., anils) revealed the importance of the present structural environment causing a
significant influence on the physical properties [3]. In that case, the polymorphs of the anils under
study differ not only in color but also in their photochromic behavior. Results of Harada et al. showed
the opportunity of accessing the photochromic properties of spiropyran and spirooxazine compounds
at low temperature in the solid state by suppressing the thermal back reaction [4]. Combining these
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two insights, we consider the importance of a basic knowledge about the polymorphic situation of
spiropyran and spirooxazines not only as inevitable but also necessary to find a suitable way to enter
the photochromism in the solid state.
Thus, our first investigation on this matter set priorities on the intermolecular interactions
possibly leading to different arrangements of the analyzed compounds in the crystal lattice.
Hereby, mostly non-covalent interactions like van der Waals interactions and hydrogen bonds were
decisive and were our main focus [5]. For the commercially available photochromic compounds
that are the target of this work, little to no structural information was available. A search in
the Cambridge Structural Database (CSD, Version 5.37, May 2016) [6], restricted to organic and
not polymeric structures yielded no match for 1,3,3-Trimethylindolinobenzopyrylospiran (SP) nor
1,3,3-Trimethylindolino-8′-methoxybenzopyrylospiran (SPOMe). Only one hit was found for both
1,3,3-Trimethylindolinonaphtospirooxazine (SOBenz; CSD Refcode JIZJOR/01/02 [4,7], polymorph I;
JIZJOR03 [8], polymorph II) and 1-(2-Hydroxyethyl)-3,3-dimethylindolino-6′-nitrobenzopyrylospiran
(SPEtNO2; CSD Refcode IHOFOA) [9]. In order to gain further information on the preferred interaction
within crystalline spiro materials, we performed a structural study on the series of commercially
available spiro compounds (Scheme 1) with the goal to gain an overall structural understanding of
their interaction patterns. Within this context, we identified five novel crystal structures.
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2. Results
For 1,3,3-Trimethylindolinobenzopyrylospiran (SP), no crystal structure was identified in the
literature. (I) crystallizes in the monoclinic space group P21/c with one molecule in the asymmetric
unit (Figure 1a). Bound together via a spiro junction (C10), the indoline plane (r.m.s. deviation for all
non-H-atoms excluding C10 = 0.014 Å) and the chromene plane (r.m.s. deviation for all non-H-atoms
excluding C10 = 0.023 Å) shows a dihedral angle of 80.03 (3)◦ with a distance for the indoline plane of
0.4528 (14) Å and 0.3081 (13) Å for the chromene plane to the chiral spiro center (C10). The CSpiro-O
bond length is 1.4714 (13) Å and the CSpiro-N bond length is 1.4456 (15) Å. The crystal packing shows
isolated units without specific intermolecular interactions (Figure 1b).
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(C10) from the above defined planes for the indoline part of respectively 0.360 (4) Å  for A; 0.365 (4) Å  
for B, 0.371 (4) Å  for C and 0.375 (4) Å  for D and for the chromene part of respectively 0.399 (4) Å  for 
A, 0.342 (4) Å  for B, 0.168 (4) Å  for C and 0.249 (4) Å  for D. Within the asymmetric unit, two S- and 
two R-enantiomers are observed. The CSpiro-O-bond length is on average 1.459 (4) Å  (1.458 (4) Å  for A 
and D; 1.461 (4) Å  for B and 1.460 (4) Å  for C). The CSpiro-N-bond length is on average 1.442 (5) Å  
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1,3,3-Trimethylindolinonaphthospirooxazine, (SOBenz), has two known polymorphic crystal
structure in the CSD crystallizing i t e orthorhombic space group Pbca and P21 (CSD Refcode
JIZJOR/01/02 and JIZJOR03, respectiv ly). Here, we identified noth r structure (II) for this
compound, which crystallizes in the monoclinic space group Pc with four molecules in the asymmetric
unit (A, B, C and D; Figure 2a). Each of the molecules show a different dihedral angle between the
indoline plane (r.m.s. deviation for all non H-atoms excluding C10 = 0.020 Å for A; 0.020 Å for B;
0.026 Å for C and 0.021 Å for D) and the benzochromene plane (r.m.s. deviati n for all non H-atoms
excluding C10 = 0.046 Å for A; 0.043 Å for B; 0.013 Å for C and 0.022 Å for D), of respectively: A: 79.74
(8)◦; B: 81.99 (10)◦; C: 86.46 (9)◦; D: 83.75 (8)◦. This leads to a distance of the chiral spiro center (C10)
from the above defined planes for the indoline part of respectiv ly 0.360 (4) Å for A; 0.365 (4) Å for
B, 0.371 (4) Å for C and 0.375 (4) for D and for the chromene part of respectively 0.399 (4) Å for A,
0.342 (4) Å for B, 0.168 (4) Å for C and 0.249 (4) Å for D. Within the asymmetric unit, two S- and two
R-enantiomers are observed. The CSpiro-O-bond length is on average 1.459 (4) Å (1.458 (4) Å for A and
D; 1.461 (4) Å for B and 1.460 (4) Å for C). The CSpiro-N-bond length is on average 1.442 (5) Å (1.434 (4)
Å for A, 1.443 (5) Å for B, 1.446 (5) Å for C and 1.445 (5) Å for D). In the crystal packing (Figure 2b) no
strong intermolecular interactions are observed showing A and C as well as B and D related through
a pseudo twofold axis along a.
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For 1-(2-Hydroxyethyl)-3,3-dimethylindolino-6′-nitrobenzopyrylospiran, (SPEtNO2), a single
entry was found in the CCD, with the compound crystallizing in the monoclinic space group I2/a
(IHOFOA). We obtained a polymorphic form for this compound, (III), which crystallizes in the triclinic
space group P1 with two disordered molecules in the asymmetric unit capturing the S- (A) and the
R-Conformer (B), (Figure 3a). The indoline plane (r.m.s. deviation for all non H-atoms excluding
C10 = 0.017 Å for A and 0.016 for B) and the chromene plane (r.m.s. deviation for all non H-atoms
excluding C10 = 0.018 Å for A and 0.014 Å for B) present a dihedral angle of 88.61 (12)◦ for A and 89.45
(11)◦ for B with the chiral center displaced by 0.402 (5) Å for A and 0.405 (5) Å for B from the indole
plane and 0.073 (8) Å for A and 0.046 (7) Å for B from the chromene moiety. The CSpiro-O-bond length
is 1.485 (5) Å for A and 1.488 (5) Å for B. The CSpiro-N-bond length is 1.427 (6) Å for A and 1.426 (6) Å
for B. In the crystal packing, molecules of A and B are isolated, showing no specific intermolecular
interactions (Figure 3b).
For 1,3,3-Trimethylindolino-8′-methoxybenzopyrylospiran, (SPOMe), we were able to crystallize
two polymorphs, (IVa) and (IVb). (IVa) belongs to the monoclinic space group P21/c, with two
molecules in the asymmetric unit (A and B; Figure 4a). The dihedral angle of the indoline plane (r.m.s.
deviation for all non H-atoms excluding C10 = 0.014 Å for A and 0.017 Å for B) and chromene plane
(r.m.s deviation for all non H-atoms excluding C10 = 0.049 Å for A and 0.028 Å for B) encloses 77.06
(3)◦ for A and 79.11 (4)◦ for B. For molecule A, the distance to the chiral center C10 is 0.382 (2) Å for the
indoline plane and 0.326 (2) Å for the chromene plane. The respective distances in B are 0.394 (2) Å
and 0.311 (2) Å. The arrangement of the methoxy substituent is in both cases antiperiplanar to C2 and
slightly rotated out of the planar indoline part (2.29 (2)◦ for A and 6.13 (2)◦ for B). The CSpiro-O bond
shows a length of 1.4635 (19) Å for A and 1.4672 (18) Å for B and the CSpiro-N bond a length of 1.445 (2)
Å for both A and B. In the crystal packing (Figure 4b), additional intermolecular C-H . . . O van der Waals
interactions are formed for A (C23A-H . . . O1Ai; C23A-H . . . O22Ai) as well for B (C23B-H . . . O1BiI;
C23B-H . . . O22BiI) around the inversion center. [Symmetry code: (i) 2 − x, 1 − y, 1 − z; (ii) 1 − x,
1 − y, 1 − z].
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Figure 4. (a) A perspective view of (IVa), showing the atom-numbering scheme. Displacement 
ellipsoids are drawn at the 50% probability level. (b) A partial packing diagram for (IVa). Unique 
Van-der-Waals interactions are indicated as green dashed lines. [Symmetry code: (i) 2 − x, 1 − y, 1 − z; 
(ii) 1 − x, 1 − y, 1 − z]. 
The polymorphic structure (IVb) crystallizes in the triclinic space group P1̅. The asymmetric unit 
contains one molecule for which the indoline plane (r.m.s. deviation for all non H-atoms excluding 
C10 = 0.022 Å ) and chromene plane (r.m.s. deviation for all non H-atoms excluding C10 = 0.032 Å ) 
enclose a dihedral angle of 78.07° (3). The distance to the chiral center C10 is 0.3849 (17) Å  for the 
indoline plane and 0.2836 (18) Å  for the chromene plane. The methoxy substituent is slightly rotated 
outwards by 1.81° (2) with respect to the indoline plane and takes an antiperiplanar arrangement to 
C2. The CSpiro-O and CSpiro-N bonds show respectively bond lengths of 1.4672 (16) Å  and 1.444 (2) Å . 
In the crystal packing weak C-H…O van-der Waals interactions (C23-H…O1i; C23-H…O22i) are 
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The polymorphic structure (IVb) crystallizes in the triclinic space group P1. The asymmetric unit
contains one molecule for which the indoline plane (r.m.s. deviation for all non H-atoms excluding
C10 = 0.022 Å) and chromene plane (r.m.s. deviation for all non H-atoms excluding C10 = 0.032 Å)
enclose a dihedral angle of 78.07◦ (3). The distance to the chiral center C10 is 0.3849 (17) Å for the
indoline plane and 0.2836 (18) Å for the chromene plane. The methoxy substituent is slightly rotated
outwards by 1.81◦ (2) with respect to the indoline pl ne and takes an antiperiplanar arrangem nt to
C2. The CSpiro-O and CSpiro-N bonds show respectively bond lengths of 1.4672 (16) Å and 1.444 (2) Å.
In the crystal packing weak C-H . . . O van-der Waals interactions (C23-H . . . O1i; C23-H . . . O22i) are
obtained similar to structure (IVa) (Figure 5b). [Symmetry code: (i) − x, 1 − y, 1 − z].
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3. Discussion
A closer look at the structural features shows a high similarity between the different compounds.
All compounds crystallize out as racemic compounds, containing both R and S enantiomers (Table A1).
Furthermore, in all cases, the indoline heterocycle plane (excluding the central chiral center C10) shows
the arrangement of a flattened envelope with a distance of approximately 0.4 Å to the chiral center
C10. The chromene plane (excluding the C10 atom) makes an angle with respect to the first plane.
All angles can be found in a 13◦ range from one another. A strict overlay of the indoline heterocycles in
all five crystal structures (Figure 6a) shows the structural variety of the chromene plane. The distance
of the latter plane to the chiral center C10 varies from 0.4 Å to 0.0 Å. The chromene plane can bend
either towards the geminal methyl groups or away from these. Focusing on chromene heterocyles of
structural related entries in the CSD (CUTQUQ01 [4], CUTCUQ 02 [10], FURBUP [11], KACLOQ [12],
KOCWOO [13]) the same flexibility of the angle is observed (Figure 6b).
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Figure 6. (a) Structure overlay of structure (I)–(IV) by superposing the indoline heterocycle, excluding
C10. (b) Structure overlay of structural related entries in the CSD, showing the same type of
superposition with focus on the chromene heterocycle.
However, in all structures the typical weakening of the CSpiro-O bond to 1.47 Å is observed,
which correspond to the bond length indicated for spiropyrans and spirooxazines in all known crystal
structures of the CSD. The bond lengths extensions amount 0.06 Å compared to normal C-O bonds
(1.41 Å) in six-membered heterocylces extracted from overall crystal structures in the CSD database.
Simultaneously, the strengthening of the CSpiro-N bond agrees with the gained results. It is shortening
in average about 0.03 Å from 1.47 Å for C-N bonds in five-membered heterocycles to 1.44 Å in
spiropyrans and spirooxazines.
Comparing the structures (I)–(IV), no strong interactions in terms of inter- or intramolecular
hydrogen bonding are observed. Even introduction of additional functional groups, such as -NO2
and -OMe, only lead to weak C-H . . . O interactions as shown in structures (IVa) and (IVb) by two
facing methoxy groups in a R22(8) motif. In all cases, the methoxy group shows an approximate
coplanar arrangement compared to the chromene plane, with atoms C4 and C23 adopting a
synperiplanar conformation.
A CSD search of spiropyran and spirooxazine compounds with one or more methoxy substituents
connected to the chromene moiety (restricted to organic and not polymeric structures; selection of
one polymorph per data set) yielded three hits (ETURAM [14], FUWHIO [11] and WILBUO [15];
Scheme 2). In ETURAM, a similar interaction is given by the methoxy group compared to (IVa) and
(IVb). This is also displayed by one of the methoxy substituents in WILBUO. Another R22(7) van
der Waals interaction can be formed in FUWHIO. In every presented crystal structure, an almost
coplanar arrangement of the methoxy substituent with respect to the chromene heterocycle is found.
A nitro substituent attached to a Spiropyran molecule, for example in (III) and IHOFOA shows less
directionality resulting in weak N-O . . . H van der Waals contacts in direct comparison to a methoxy
group, yet the coplanar arrangement regarded to the chromene moiety is maintained.
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A direct comparison of the structural polymorphic pairs (III) and IHOFOA, (II) and JIZJOR03 as
well as (IVa) and (IVb) show high similarity in the packing features. Whereas the first-mentioned pair
can be assumed to be temperature polymorphs, the remaining pairs show an almost perfect overlay,
despite different space groups. Close examination reveals that JIZJOR03 structure was determined
using inappropriate selection of unit cell settings, most probably due to weak diffraction of the crystal
on Mo radiation. The author refined the resulting structure using twinning and disorder in order to
describe the structure using their model. Transformation matrix from our unit cell setting to their
setting is (0 1 0, −1 0 0, 0.5 −0.5 1). This situation became possible due to an unfortunate combination
of circumstances: Z′ = 4 and packing features of the structure.
The gained insights into the five new presented crystal structures are helpful in order to improve
the basic understanding of the intermolecular interactions occurring in the solid state necessary
to selectively modify the crystal structure for any future work. With the aid of the additional
gained knowledge of the polymorphism we intend to engineer the crystal structure selectively in our
upcoming work.
4. Materials and Methods
4.1. Materials
Compounds I to IV were purchased from TCI chemicals (racemic mixture) and used without
further purification.
4.2. Crystallization
Crystals of (I)–(IV) were obtained by isothermal solvent evaporation using various solvents
(Table 1). All crystallization experiments were performed at room temperature (22 ◦C ± 2 ◦C).
Table 1. Crystallization 1 of 1,3,3-Trimethylindolino-benzopyrylospiran (I), 1,3,3-
Trimethylindolinonaphthospirooxaxine (II), 1-(2-Hydroxyethyl)-3,3-dimethylindolino-6′-
nitrobenzopyrylospiran (III), 1,3,3-Trimethylindolino-8′-methoxybenzopyrylospiran (IVa,b).
Crystal Amount (mg, mmol) Solvent
(I) 2.1, 0.008 Methanol (100 µL)
(II) 2.7, 0.008 Acetone (75 µL)
(III) 50.0, 0.142 Ethanol (4 mL)
(IVa) 31.2, 0.101 Ethanol (4 mL)
(IVb) 4.2, 0.014 Ethanol (300 µL)
1 All crystallization experiments were performed at room temperature.
4.3. Data Collection & Refinement
Single-crystal X-ray diffraction data for (I)–(II) and (IVa,b) were collected on a the Oxford
Diffraction Gemini R Ultra diffractometer (Oxford Diffraction Ltd., Abington, UK; 4-circle kappa
platform, Ruby CCD detector) using Mo Kα (λ = 0.71073 Å) (for (I) and (IVa)) and Cu Kα (λ = 1.54184 Å)
(for (II) and (IVb)) radiation. Measurements for crystal (III) were performed on a Mar345 image plate
(Xenocs Fox3D mirrors) using Mo Kα (λ = 0.71073 Å) radiation (Rotating anode Rigaku UltraX 18S).
The crystals of III were flash cooled to 150 K in a nitrogen gas flow prior to data collection.
Crystal data, data collection, and structure refinement for all structures were carried out using
the CrysAlis PRO software package [16] and SHELXL-2014 [17]. Non-hydrogen atoms were refined
anisotropically. All H atoms were located initially by difference Fourier syntheses. Carbon-bound H
atoms were placed in calculated positions and refined using a riding model with Uiso(H) = 1.5 Ueq(C)
for methyl or 1.2 Ueq(C) of the parent atom for secondary and aromatic H atoms. For the H atoms
of the methyl groups, free rotation about their threefold axis was allowed. Symmetry analysis was
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followed by PLATON [18]. Figures of the asymmetric unit and crystal packing was created by using
XP in SHELXTL-Plus [19] and Mercury [20].
In (III), both -CH2-CH2-OH side chains in position N20A/B are disordered over several positions
[site-occupancy factor for the major-occupied orientation = 0.654 (14) for A and 0.667 (10) for B]. A large
cavity is present in the crystal structure (508 Å3). The PLATON SQUEEZE algorithm was used to
analyze this void and a total of 110 e− were detected and replaced by a uniform electron density filling
up the cavity. Given that the voids in structure III are located in open channels, it is likely that part of
the solvent molecules have evaporated, partially explaining the limited diffraction observed.
4.4. Analysis of Structural Parameters
For structure comparison, several parameters were defined and calculated using the SHELXL-2014
software (Figure 7). A least-squares plane is calculated through the atoms C11, C14, C15, C16, C17,
C18, C19, N20 for the indoline part and by the atoms O1, C2, C3, C4, C5, C6, C7, C8, C9 for the
chromene plane. The deviations for all included atoms from the plane are listed with estimated
standard deviations (→ r.m.s.d). Further the distance of each defined plane to the chiral spiroatom C10
is determined as well the angle between the planes. CCDC 1529772-1529776 contain the supplementary
crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Data
Centre via www.ccdc.cam.ac.uk/structures.
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Appendix A
Table A1. Summary table of information given about the crystal structures in the main text.
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1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth lin d olin o-8’m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-be zop yr osp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth lin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2 H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Tr m eth ylin d olin n ap h th osp irooxaxin e
1-(2-H yd r x eth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yryl sp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-




1,3,3-Trim eth ylin d olin o-ben z p yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
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Appendix A 
Table A1. Summary table of information given about the crystal structures in the main text. 
St ucture Molecule r ation 
r. .  (X) 
 










d ( piro-N) 
[ ] 
  
        
I - Rac 0.014 0.4528 (14) 0.023 0.3081 (13) 80.03 (3) 1.4714 (13) 1.4456 (15) 
II A Rac 0.020 0.360 (4) 0.046 0.399 (3) 79.74 (8) 1.458 (4) 1.434 (4) 
 B  0.020 .365 (4) 0.043 . 42 (4) 81.99 (10) . 6  (4) . 3 (5) 
 C  0.026 0.371 (4) 0.013 0.168 (4) 86.46 (9) 1.460 (4)  1.4 6 (5) 
 D  0.021 0.375 (4) 0.022 0.249 (4) 83.57 (8) 1.458 (4) 1.4 5 (5)  
III A Rac 0.017 0.402 (5) 0.018 0.073 (8) 88. 1 (12) 1.485 (5) 1.427 (6) 
 B  0.016 0.405 (5) 0.014 0.046 (7) 89.45 (11) 1.488 (5) 1.426 (6) 
IV A Rac 0.014 0.382 (2) 0.049 0.326 (2) 77.06 (3) 1.4635 (19) 1.445 (2) 
 B  0.017 0.394 (2) 0.028 0.311 (2) 79.11 (4) 1.4672 (18 1.4 5 (2) 
V - Rac 0.022 0.3849 (17  0.032 0.28 6 (18  78.07 (3) 1.4672 (16) 1.4  (2) 
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-T im eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zo y ylosp iran
d*
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim h ylin d ol n o-ben zop yrylosp iran 1,3,3-Tr m eth ylin d olin n ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-be zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H d roxyeth yl)-3,3-d im eth ylin d olin o
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d ol n o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2 H yd rox eth yl)-3,3 d im eth lin d ol n -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
be zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2 H yd rox eth yl)-3,3 d im eth lin d ol n -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl) 3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Tr m eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Tr m eth lin d olin o-8’m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d o o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop rylosp iran
1,3,3-Trim eth lin d olin o-8’m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d lin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d o o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3,3- im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d o o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-be zop yr osp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im th lin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2 H yd r xyeth yl)-3,3-d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3,3-Tr m eth ylin d ol n o-8’-m eth xy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H d roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1 ,3-Tr m eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Tr m eth ylin d olin n ap h th osp irooxaxin e
1-(2-H yd r x eth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yryl sp iran
d
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yryl sp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-




1,3,3-Trim eth ylin d olin o-ben z p yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
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Appendix A 
Table A1. Summary table of information given about the crystal structures in the main text. 
Structure Molecule Conformation 
r. .s.d. (X) 
[Å] 
d ( - piro) 
] 
r. . .  ( ) 
 
d (Y-CSp o) 
[  







        
I - Rac 0.014 0.4528 (14) 0.023 0.3081 (13) 80.03 ( ) 1.4714 (13) 1.4 56 (15) 
I  A Rac 0.020 0.360 (4) 0.046 0.39  (3) 79.74 (8) 1.458 (4) 1.434 (4) 
 B  0.02  0.36  (4) 0.043 0.342 (4) 81.9  ( 0) 1.461 ( ) 1.4 3 (5) 
 C  0.026 0.371 (4) 0.013 0.168 (4) 86.46 (9) 1.460 (4) 1.4 6 (5) 
 D  0.021 0.375 (4) 0.02  0.249 (4) 83.57 (8) 1.458 (4) 1.4 5 (5) 
I  A Rac 0.017 0.402 (5) 0.018 0.073 ( ) 8 .61 (12) 1.485 (5) 1.427 ( ) 
 B  0.016 0.405 (5) 0.014 0.046 (7) 89.45 (1 ) 1.48  (5) 1.426 (6) 
IV A Rac 0.014 0.382 (2) 0.049 0.326 (2) 7 .06 (3) 1.4635 (19) 1.4 5 (2) 
 B  0.017 0.39  (2) 0.028 0.31  (2) 79.1  (4) 1.4672 (18) 1.4 5 (2) 
V - Rac 0.02  0.3849 (17) 0.032 0.2836 (18) 78.07 (3) 1.4672 (16) 1.4  (2) 
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Tr m eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)- , -d im in d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-be zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop y ylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop y ylosp ira
d*
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth yl n d lin o ap h th osp ro xax e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Tr m eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o i o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim h ylin d ol n o-ben zop yrylosp iran 1,3,3-Tr m eth ylin d lin n ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1 im eth ylin d o o be z p yryl an 1,3,3-Tr m eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d ol n o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth xy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Tr m eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3, -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d lin -
6’-n itroben zop yrylosp iran
1,3 -Tr m eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -T im eth yli d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop rylosp iran
1,3 -Trim eth yl n d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -T im eth ylin d olin o-8’-m eth xy-
ben zop yryl sp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth yli d ol n o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m et oxy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth lin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -T im eth ylin d olin on ap h th sp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop rylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d ol n o-
6’-n i roben zop ryl sp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop rylosp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, - im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth lin d olin o-8’m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl a 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, - im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, - im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth lin d olin o-8’m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth y d o o-ben zop yryl a 1,3 Trim eth yli d ol n on ap h th osp ro x xin e
1-(2-H yd roxyeth yl)-3, - im eth ylin d olin -
6’-n itroben zop yrylosp ran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, - im eth ylin d ol n o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin -8’-m th oxy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-be zop yr osp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1 (2-H yd roxyeth yl)-3, -d im eth lin d ol n o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2 H yd roxy th yl)-3, -d im eth ylin d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im th lin d o -
6’-n itroben zop yrylosp iran
-8’-m eth oxy-
be zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Tr m eth ylin d olin o-ben zop yrylosp iran 1,3 -Tr m eth ylin d olin n ap h th osp iro xaxin e
1-(2-H yd r x eth yl)-3, -d im eth ylin d olin o-
6’n i roben z p yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin olin o-
6’-n itroben zop yryl sp ran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp ira 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -T im th ylin d o in o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d m eth lin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-




1,3 -Trim th yl n d olin o-ben z p yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H d roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
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II   .  .  ( ) .  .  ( ) .  ( ) .  ( ) .  ( ) 
   . 0 . 5 ( ) .  .  ( ) .  (1 ) .  (4) . 4  ( ) 
   .  .  ( ) .  .  ( ) .  ( ) .  ( ) .  ( ) 
   .  .  ( ) .  .  ( ) .  ( ) .  ( ) .  ( ) 
III   .  .  ( ) .  .  ( ) .  ( ) .  ( ) .  ( ) 
   .  .  ( ) .  .  ( ) .  ( ) .  ( ) .  ( ) 
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   .  .  ( ) .  .  ( ) .  ( ) .  ( ) .  ( ) 
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1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp irooxax n e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben z p yryl an 1,3 -Trim eth lin d oli on ap h th osp irooxaxin e
1-(2-H d roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop y ylosp ran
1,3 -Tr m eth y in d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben z p yryl an 1,3 -Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)- , -d im lin d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-be zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itro
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp ira
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -T im eth n d ol o ap h th sp iro xax e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben zop yryl n 1,3 -Trim eth ylin d lin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim ylin d ol n o-ben zop yrylosp iran 1,3 -Tr m eth ylin d olin n ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1, im eth ylin d o o be z p yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd oxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth xy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin -ben zop yrylosp iran 1,3 -Trim eth lin d olin ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Tr m eth y lin o-8 -m eth oxy-
1,3 -Trim eth ylin d o -ben zop yryl an 1,3 -Trim eth ylin d olin n ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d lin -
6 -n itroben zop yrylosp iran
1,3 -Tr m eth ylin d lin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -T im eth yli d olin -ben zop yrylosp ran 1,3 -Trim eth lin d olin ap h th osp iro xaxin
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth y lin o-8 -m eth oxy-
1,3 -Trim eth yl n d o -ben zop y yl an 1,3 -Trim eth ylin d olin n ap h th osp ro xax e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d lin -
6 -n itroben zop yrylosp iran
1,3 -T im th ylin d lin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin -ben zop yrylosp iran 1,3 -Trim eth ylin d olin n ap h th osp iro xaxin e
1-(2-H d roxyet in -
6 -n itrob
n o-8 -m et oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop ylosp i an
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth lin d olin o ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth lin olin o-8 m eth oxy-
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -T im eth yli d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth lin olin o-8 m eth oxy-
1,3 -Trim eth y d o o-ben zop yryl an 1,3 Trim eth ylin d ol n on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, -d im eth yl d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxy )-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp ira
-8 m eth oxy-
ben zop yr osp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n it ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben z p yrylos iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth y d olin o-be z p yr osp iran 1,3 -Tr m eth y d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth lin d olin o-
6 -n itroben zop rylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim et rylosp iran 1,3 -Trim eth ylin d olin o ap h t osp iro xa in e
1-(2 H yd roxy th yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop yrylosp iran
1,3,3-Tr m eth ylin d olin o-8 -m eth oxy-
be zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8 -m eth oxy-
1,3 -Trim eth ylin d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Tr m eth ylin d olin o-ben zop yrylosp iran 1,3 -Tr m eth ylin d olin n ap h th osp iro xaxin e
1-(2-H yd r x eth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yr osp ira
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin olin o-
6 - itro
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth yl n d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d lin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth y d olin -
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yryl sp i an
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben z p yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2 H d roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth in d oli o-
6 -n itro
1,3 -Trim eth ylin d olin o-8 -m eth oxy-
ben zop yrylosp iran
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Ap endix A 
Table A1. Sum ary table of information given about the crystal structures in the main text. 
Str cture  Conformation 








X  Y 
[°] 





        
I - Rac 0. 14 0.4528 (14) 0. 23 0.3081 (13) 80. 3 ( ) 1.4714 (13) 1.4456 (15) 
II A Rac 0. 2  0.360 (4) 0. 46 0.399 (3) 79.74 (8) 1.458 (4) 1.43  (4) 
 B  0. 2  0.365 (4) 0. 43 0.342 (4) 81.99 (10) 1.461 (4) 1.443 (5) 
 C  0. 26 0.371 (4) 0. 13 0.168 (4) 86.46 (9) 1.460 (4) 1.446 (5) 
 D  0. 21 0.375 (4) 0. 22 0.249 (4) 83.57 (8) 1.458 (4) 1.445 (5) 
III A Rac 0. 17 0.402 (5) 0. 18 0. 73 (8) 88.61 (12) 1.485 (5) 1.427 (6)
 B  0. 16 0.405 (5) 0. 14 0. 46 (7) 89.45 (11) 1.488 (5) 1.426 (6) 
IV A Rac 0. 14 0.382 (2) 0. 49 0.326 (2) 77.06 (3) 1.4635 (19) 1.445 (2) 
 B  0. 17 0.394 (2) 0. 28 0.311 (2) 79.11 (4) 1.4672 (1 ) 1.445 ( )
V - Rac 0. 22 0.3849 (17) 0. 32 0.2836 (18) 78.07 (3) 1.4672 (16) 1.44  (2) 
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp irooxax n e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop rylosp iran
1,3 -Tr m eth ylin ol n o-8’-m eth oxy-
1,3 -Trim eth ylin d o o-ben z p yryl an 1,3 -Trim eth lin d olin o ap h th osp irooxaxin e
1-(2-H yd oxyeth yl)-3, -d im eth ylin d olin -
6’-n itr ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin ol n o-8’-m eth oxy-
1,3 -Trim eth ylin d o o-ben z p yryl an 1,3 -Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im lin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-be zop yrylo p i an 1,3 -Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp ran
d*
1,3 -Trim eth ylin d olin o-ben zop yrylosp ira 1,3 T im eth yl n d ol n o p h th sp r xax e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8’-m eth oxy-
1,3 -Trim eth yl n d o o ben zop yryl a 1,3 -Tr m eth ylin d olin on ap h th sp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim h ylin d ol n o-b n zop yrylosp iran 1,3 -Tr m eth ylin d olin n ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8’-m eth oxy-
1, 3 im eth ylin d o o be z p yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd rox eth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp ira
1,3 -T im eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3 -Tr m eth ylin d olin -ben zop yrylosp iran 1,3 -Tr m eth lin d olin ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d m eth ylin d olin o-
6’-n itroben zop yrylosp iran
1 -Tr m eth ylin lin o 8’-m eth oxy-
1,3 -Tr m eth yl n d o -ben z p yryl an 1,3 -Tr m eth ylin d olin n ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d m eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Tr m eth ylin d lin o 8’-m eth oxy-
ben zop yrylosp iran
1,3 -T m eth yli d olin -ben zop yrylosp ran 1,3 -Tr m eth lin d olin ap h th osp iro xaxin
1-(2-H yd roxyeth yl)-3, -d m eth ylin d olin o-
6’-n itroben zop yrylosp ran
1 -Tr m eth ylin lin o 8’-m eth oxy-
1,3 -Tr m eth yl n d o -ben z p yryl an 1,3 -Tr m eth ylin d olin n ap h th osp iro xax e
1 (2-H yd roxye h yl)-3, -d m th yli d o in -
6’-n itroben zop yrylosp iran
1,3 T m eth ylin d lin o 8’-m eth oxy-
ben zop yrylosp iran
1,3 -Tr m eth ylin d olin -ben zop yrylosp iran 1,3 -Tr m eth ylin d olin n ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
8 -m eth oxy-
iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8’-m eth oxy-
r
1,3 -Trim eth yl n d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop rylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8’-m eth oxy-
1,3 -Trim eth yl n d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth lin d lin o ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth lin olin o-8’m eth oxy-
1,3 -Trim eth yl n d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H y roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 Trim eth ylin d olin -8’-m th oxy-
ben zop yrylosp iran
1,3 -T im eth yli d olin o-ben zop yrylosp ran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd r xyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth lin olin o-8’ oxy
1,3 -Trim eth y d o o-ben zop yryl an 1,3 Trim eth ylin d ol n on ap h th osp iro x xin e
1-(2-H yd r xyeth yl)- , -d im eth yli d lin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth xy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro x xin e
1-(2-H yd roxyeth yl) 3, -d im eth yli d olin -
6’-n itroben zop yrylosp i an
1,3 -Trim eth lin d lin o-8’m e xy-
ben z p r osp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Tr m eth yl d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d oli o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8’-m eth oxy-
1,3 -T im eth yl n d o in o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d ol n o-ben zop yryl s iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8’-m eth oxy-
1,3 -Trim eth yl n d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth y d lin o-be zop yr osp iran 1,3 -Trim eth y d lin on ap h th osp iro xaxin e
1-(2 H yd rox eth yl)-3, d i lin d olin o-
6’- itroben zo ylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp ir xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8’-m eth oxy-
1,3 -Trim eth yl n d o o-ben zop yryl an 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
be zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin o ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin olin o-8’-m eth oxy-
1,3 -Trim eth yl n d o o-ben zop yryl an ,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Tr m eth yli d olin o-ben zop yrylosp iran 1,3 -Tr m eth ylin d olin n ap h th osp iro xaxin e
1-(2-H yd r x eth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
dd
1,3 -Tr m eth ylin d olin -ben zo yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd r x eth yl)-3, -d im eth ylin olin -
6’- it obe zop yrylosp r n
1,3 Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d o in o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2 H yd roxyeth yl)-3, -d im eth y d o o-
6’-n itroben zop yrylos iran
1,3 -Trim eth yl n d olin o-8’-m eth oxy
ben zop yrylosp iran
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-




1,3 -Trim eth yl n d olin o-ben z p yrylosp iran 1,3 -Trim eth ylin d ol on ap h th osp iro xaxin e
1-(2-H d roxyeth l) 3, -d m eth yli d olin o-
6 itroben zop yr osp ira
1,3 Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3 -Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3, -d im eth ylin d olin -
6’-n itroben zop yrylosp iran
1,3 -Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
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Appendix A 
Table A1. Sum ary table of information given about the crystal struct res in the main text. 









  Y 
[°] 





        
I - Rac 0.014 0.4528 (14) 0.023 0.3 81 (13) 80.03 (3) 1.4714 (13) 1.4456 (15) 
II A Rac 0.020 0.360 (4) 0.046 0.399 (3) 79. 4 (8) 1.458 (4) 1.434 (4) 
 B  0.020 0.365 (4) 0.04  0.342 (4) 81.99 (10) 1.46  (4) 1.443 (5) 
 C  0.026 0.371 (4) 0.013 0.168 (4) 86.4  ( ) 1.460 (4)  1.446 (5) 
 D  0.021 0.375 (4) 0.022 0.249 (4) 83.57 (8) 1.458 (4) 1.445 (5)  
III A Rac 0.017 0.4 2 (5) 0.018 0.073 (8) 88.61 (12) 1.485 (5) 1.427 (6) 
 B  0.016 0.4 5 (5) 0.014 0.046 (7) 89.45 (11) 1.488 (5) 1.426 (6) 
IV A Rac 0.014 0.382 (2) 0.049 0.326 (2) 77.06 (3) 1.4635 (19) 1.445 (2) 
 B  0.017 0.394 (2) 0.028 0.311 (2) 79.11 (4) 1.4672 (18) 1.445 (2) 
V - Rac 0.022 0.3849 (17) 0.032 0.2836 (18) 78.07 (3) 1.4672 (16) 1.444 (2) 
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d o on ap h th osp ir oxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth y d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yryl sp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3 -Trim eth ylin d o on ap h th osp ir oxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1, ,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth y d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
,3,3-Trim eth ylin d olin o-ben zop yrylosp iran n ap h th sp ir xaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yryl sp iran
dd
1,3,3-Trim eth ylin d olin o-ben zop yrylosp i an 1,3,3-Trim eth ylin d olin on ap h th osp iro xaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yryl sp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d*
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1 (2-H yd r x eth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-T im eth ylin olin o-8’-m eth oxy-
be sp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl) th y d olin
6’-n itroben zop yrylosp i an
-Trim eth in d oli o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim h ylin d ol n o-ben zop yrylosp iran 1 3,3-Tr m eth ylin d olin n ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-be zop yr l an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth y d olin -
6’-n itroben zop yrylosp i an
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth y d olin -
6 -n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp ira
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-T im eth yli d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3 Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o n o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1 (2-H yd roxy yl)-3,3-d im eth y d olin -
6’-n itroben zop yrylosp an
1,3,3 Trim eth lin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-be zop yr losp iran 1,3 -Trim eth ylin d lin a h t osp iroox x
1-(2-H yd r xyeth l)-3,3-d m eth ylin d lin o-
6’-n itroben zop yrylosp iran
1,3,3-T im eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp ir n
1,3,3-Trim eth ylin d olin o-ben zop rylosp an 1,3,3-Trim th ylin d o in on ap h th osp o xaxi e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1 3 Trim eth ylin d olin o 8’m eth o -
ben zop yrylosp iran
1,3,3-Trim eth ylin d o-ben zop yl ra 1,3,3-Tr m th ylin d in on ap h th sp irooxaxin e
1-(2-H d roxyeth yl)-3,3-d im eth y d olin -
6’-n itroben zop yrylosp iran
1 3 Trim eth ylin d olin o 8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth y d olin -
6’-n itroben zop yrylosp i an
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yr l sp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben z p rylosp iran
d
1,3,3-Trim eth ylin d olin o ben zop yr osp ran 1,3,3-Trim eth ylin d olin on ap th osp ro x xi e
1-(2-H yd r xyeth yl)-3,3 d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth li d ol o 8’ oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp ro x xi e
1-(2-H yd roxyeth l)-3,3 d im eth y d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o 8’- oxy-
ben z p rylosp iran
1,3,3-Tr m eth ylin d olin o ben zop y osp ran 1,3,3-Trim eth yli d lin on a th sp ro x xi e
1-(2-H yd roxyeth yl)-3,3 d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3, -Trim eth lin d olin o 8’ oxy-
ben zop yrylosp iran
1,3,3-Tr m eth ylin d o ben zop y ylo an 1,3,3-Trim eth y d lin on ap h th sp ro x xi e
1-(2-H yd roxyeth yl)-3,3 d im eth y d olin -
6’-n itroben zop yrylosp i an
1,3,3-Trim eth ylin d oli o 8’- x -
ben zop yrylosp ran
1,3,3-Trim eth ylin d olin o ben zop yryl sp ran 1,3,3-Trim eth ylin d ol n on ap h sp r x xi e
1-(2-H yd roxyeth yl)-3,3 d im eth ylin d o o-
6’-n itroben zop yrylosp iran
1,3,3-Trim th ylin d o in 8’ oxy-
ben zop yrylosp iran
d
1,3,3-T im eth ylin d olin o-ben zop y ylosp ira 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin olin o
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth y d olin -
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth )-3,3-d
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth y d olin -
6’-n itroben zop yrylosp i an
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim e ylin d li o-be zop yr osp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2 H d roxyeth yl) 3,3-d im eth lin d olin o-
6’- itroben zop yrylosp iran
1,3,3 Tr m eth lin d o in o-8’-m eth oxy-
ben zop yrylosp iran
d
,3 eth ylin d olin o-ben z p y ylosp iran 1,3,3-Tr m eth ylin d olin on ap h th osp irooxaxin
1-(2 H yd roxyeth yl)-3 -d im eth yl n d lin o-
6 -n it oben zop yrylosp iran
1,3,3-Trim eth ylin d olin o 8’- xy-
ben zo yrylos iran
1,3,3-Trim eth y d o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin
-(2-H yd rox eth yl)- ,3 d i eth y d o -
6’-n itr ben zo y ylos iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp ran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1 (2-H yd roxyeth yl)-3,3-d im eth yl n d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d o o-ben zop yryl an 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth y d olin -
6’-n troben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp ran ,3 ap h th os iro xax n e
1-(2-H yd r x eth y )-3,3-d im eth yl n d olin o-
6’n itroben zop r sp ra
1,3,3-Trim eth ylin d olin o 8’m eth -
ben z p yrylosp iran
dd
1,3,3-Tr m t ylin d olin o-be zop yrylosp iran 1,3,3-Tr m eth yl d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin -
6’-n itroben zop yryl sp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth in d oli o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-T m eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d ol n o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd r x eth y )-3,3-d im e h ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m th oxy-
ben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran ,3 n ap h th osp iro xaxin e
1- 2-H yd roxy th yl)-3,3-d im th ylin d o in o-
6’-n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-




1,3,3-Trim eth ylin d olin -be z p yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd roxyeth yl)-3,3-d im eth ylin d olin o-
6 -n itroben zop yrylosp iran
1,3,3-Trim eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
1,3,3-Trim eth ylin d olin o-ben zop yrylosp iran 1,3,3-Trim eth ylin d olin on ap h th osp irooxaxin e
1-(2-H yd oxyeth yl)-3,3-d im eth ylin d olin o-
6’-n itroben zop yrylosp iran
1,3,3-T im eth ylin d olin o-8’-m eth oxy-
ben zop yrylosp iran
d
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1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d oli n ap th osp iroo axin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d o o-be zo ryl an 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d lin
6 -n itroben zop rylosp iran
1 ,3-T im eth ylin d olin o-8 -m eth oxy-
ben z p rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d oli n ap th osp iroo axin e
1-(2 H yd oxyet )- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3- th yl n d olin o-8 -m eth x -
ben zop rylosp iran
1 ,3-Trim eth ylin d o o-be zo ryl an 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H yd roxyeth yl) ,3-d im eth ylin d li
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth xy-
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin o-8 -m eth oxy-
ben zop r osp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H yd roxyeth yl)- ,3 d im eth ylin d olin o-
6 n itroben zop osp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zo rylosp ran
1 ,3-Trim eth ylin d ol n o-ben z p ryl sp iran 1 ,3-Trim eth ylin d o n ap osp r xaxin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin -8 m eth oxy-
ben zo rylosp iran
1 ,3-Tr m eth ylin d o-be z ryl an 1 ,3-Tr m eth yl n d lin o a th osp irooxax e
1-(2-H yd roxyeth yl)- ,3-d m eth ylin d olin -
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim h ylin ol n o-ben zop rylosp iran 1 ,3-Tr th ylin d n ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin -8 -m eth oxy-
ben zo rylosp iran
1 ,3-Trim eth y d -be zo ryl an 1 ,3-Trim et ylin d olin on ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d m eth ylin d olin -
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d olin on ap th osp irooxaxin e
1-(2-H yd r xyeth yl)- ,3-d im eth ylin d olin o
6 -n itroben zop rylosp iran
1 ,3-T im eth ylin d ol n o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim th ylin d o i o-be zop rylosp iran 1 ,3-Trim et ylin d oli n ap th osp irooxaxin e
1-(2 H yd roxyeth yl)- ,3-d im eth yl n d olin o
6 -n itrobe zop rylosp iran
1 ,3-Trim eth l n d ol n o-8 -m eth oxy-
be zop rylosp iran
1 ,3-Trim th in d o o-be zo ryl an 1 ,3-Trim et ylin d olin on ap th osp irooxaxin e
1-(2-H yd r xyeth yl)- ,3-d m eth ylin d ol n -
6 -n itrobe zop rylosp ira
1 ,3-Trim eth ylin d olin o-8 -m eth y-
be zop ryl sp iran
1 ,3-Trim th ylin d o i o-be zop rylosp i an 1 ,3-Trim et ylin d oli n ap th osp irooxax e
1-(2 H yd roxyeth yl)- ,3-d im eth ylin d olin o
6 -n itrobe zop r osp iran
1 ,3-Trim eth l n d olin o-8 -m eth oxy-
be zo rylosp iran
1 ,3-T im th i d o o-be zo r an 1 ,3-Trim et ylin d olin on ap th osp rooxaxin e
1-(2-H yd r xyeth yl)- ,3-d m eth ylin d ol n -
6 -n itrobe z p rylosp iran
1 ,3-Trim eth yl n d olin o-8 m eth oxy-
be zop rylosp iran
1 ,3-Trim th in d o i o-be zop rylosp iran 1 ,3-Trim et y d olin on ap th osp irooxaxin e
1-(2-H d roxyeth yl)- ,3-d im eth ylin d lin o-
6 -n itr be zop rylosp iran
1 ,3-Tr m eth ylin d lin o-8 -m eth oxy-
be zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp ran 1 ,3-Trim eth ylin d oli n ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin o-8 -m eth oxy
ben zop r losp ira
1 ,3-Trim eth ylin d o o-be zo ryl an 1 ,3-Trim eth ylin d olin on ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d m eth ylin d olin -
6 -n itroben z p r losp iran
1 ,3 Trim eth ylin d o in -8 m eth oxy-
ben zop ryl sp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d oli n ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin o-8 -m eth oxy-
ben zo rylosp iran
1 ,3-Trim eth ylin d o o-be zo ryl an 1 ,3-Trim eth ylin d olin on ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d m eth ylin d olin -
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth in d olin on ap th osp irooxax n e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop ylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp ir n
1 ,3-Trim eth ylin d ol n o-ben zop rylosp iran 1 ,3-Trim eth yl n d ol ap th osp iro x xin e
1-(2-H yd roxyeth yl)- ,3-d im in d ol n o-
6 -n itroben zop ryl sp iran
1 ,3 Tr m eth l n d o o-8 m eth ox -
ben zop ryl sp iran
1 ,3-Trim eth ylin d o o be zo ryl n 1 ,3-Trim eth ylin d ol n on ap th osp iro x xin e
1-(2-H yd roxyeth yl)- ,3-d m in ol n -
6 n itroben zop ryl sp iran
1 ,3-Trim eth ylin d o o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d ol n -ben zop rylosp iran 1 ,3-Trim th yl n d ol ap th osp iro x x n e
1-(2-H yd roxyeth yl)- ,3-d im in d ol n o-
6 -n itroben z p ryl sp iran
1 ,3-Trim eth l n d o-8 m eth ox -
ben zo r sp iran
1 ,3-T im eth ylin d o o be z ryl n 1 ,3-Tr m th ylin d ol n ap th osp iro x xin
1-(2-H yd roxyeth yl)- ,3-d m in ol n -
6 -n itroben zop ryl sp iran
1 ,3-Trim eth yl n d o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d ol n o-ben zop rylosp iran 1 ,3-Trim eth ylin d ol n on ap th osp iro x xin e
1-(2-H yd roxyeth yl)- ,3-d im in ol n o-
6 -n itroben zop ryl sp iran
1 ,3-Trim eth ylin d o o-8 m eth oxy-
ben zop rylosp i an
1 ,3-Trim th ylin d olin o ben zop rylosp ira 1 ,3-Tr m eth ylin d oli n ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d in o-
6 -n it oben zop rylosp iran
1 ,3-Trim eth yl n d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d o o-be zo ryl an 1 ,3-Trim eth ylin d olin on ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d m eth ylin d olin -
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zo rylosp an 1 ,3-Trim eth ylin d oli n ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d im eth yli d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin o-8 -m eth oxy-
ben zo rylosp iran
1 ,3-Trim eth ylin d o o-be zo ryl an 1 ,3-Trim eth ylin d olin on ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d m eth ylin d olin -
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Tr m eth ylin d olin o-be z p r osp a 1 ,3-T im eth ylin d olin on ap th osp irooxaxin e
1-(2-H yd roxyeth yl) ,3-d m eth lin d olin o-
6 -n it ob z p rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d oli n ap th osp irooxaxin e
1 (2 H yd rox eth yl) ,3 d im eth ylin d olin o-
6’-n trobe zop rylosp iran
1 ,3-Trim eth yl n d l h -
be zop rylosp iran
,3 in d o o-be zo ryl an 1 ,3-Trim eth ylin d olin on ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d m eth ylin d olin o-
6 -n itrobe zop rylosp ira
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop ryl sp iran
1 ,3-Trim eth ylin d olin o ben zop rylosp iran 1 ,3-Trim eth ylin d oli n ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d o o-be zo ryl an 1 ,3-Trim eth ylin d olin on ap th osp irooxaxin e
1-(2-H yd roxyeth yl)- ,3-d m eth ylin d olin -
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Tr m eth ylin d ol n n ap th osp irooxaxin e
1-(2-H yd r x eth yl)- ,3-d im eth ylin d olin o-
6 -n i r ben z p losp ran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop r losp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d olin on ap th osp irooxaxin e
-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n tr b n z p ry sp iran
1 ,3-Trim eth ylin d olin o-8 -m eth ox -
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-T im eth yli d olin on ap th osp iroo axin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1,3,3-Trim eth ylin d olin o-8 -m eth oxy
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp ira 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop ryl sp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H d oxyeth yl)- ,3-d m eth ylin d olin o-
6 n zop r losp iran
1 ,3 eth ylin d lin o-8 -m eth oxy-
en zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H yd roxyeth yl)- ,3-d im eth in d olin o-
6 -n itroben zop rylosp iran
1 ,3-Trim eth yl n d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Tr m eth ylin d olin o-be z p ryl ran 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
1-(2-H yd r xyeth yl)- ,3-d im eth ylin d olin o-
6’-n i roben zop ryl sp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
1 ,3-Trim eth ylin d olin o-ben zop rylosp iran 1 ,3-Trim eth ylin d olin on ap th osp iroo axin e
-(2-H yd roxyeth yl)- ,3-d im eth ylin d olin o-
6 -n itroben z p rylosp iran
1 ,3-Trim eth ylin d olin o-8 -m eth oxy-
ben zop rylosp iran
I - Rac 14 .4528 ( 4) 2 0.3 81 3 80.03 (3) 1.47 ( 3 56 (1 )
II A Rac 0 60 ( ) 46 .399 3 79.7 (8) 1.458 ( ) 34 (4)
B 0 6 ( ) 43 .3 2 81.99 (10) . 6 ( ) 3 (5)
C 0. 26 0.371 (4) 0.013 .168 (4) 86.4 (9) 1.460 ( ) 1.4 (5)
D 0. 21 0.375 (4) 0.022 0.249 (4) 83.57 (8) 1.458 ( ) 1.4 5 (5)
III A Rac 0.017 0.402 (5) 0.018 0.073 (8) 88.61 (12) 1.485 (5) 1.427 (6)
B 0.016 0.405 (5) 0.014 0.046 (7) 89.45 (11) 1.488 (5) 1.426 (6)
IV A Rac 0.0 4 0. 82 (2) 0.049 0. 26 (2) 77.06 (3) 1.4635 (19) 1.445 (2)
B 0.017 0.394 (2) 0.02 0.311 (2) 79.11 (4) 1.4672 (18) 1.445 (2)
V - Rac 0.022 0.3849 (17) 0.032 0.2836 (18) 78.07 (3) 1.4672 (16) 1.444 (2)
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Scheme A1. Presentation of the analyzed results obtained from the CSD search restricted to organic 
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